Purpose: To compare posterior capsular opacification (PCO) between a combined procedure and a sequential procedure of pars plana vitrectomy (PPV) and cataract surgery (CS). Methods: The medical records of 89 eyes of 85 patients who underwent PPV and CS were retrospectively reviewed. There were 56 eyes of 52 patients with a combined PPV and CS (the combined surgery group), and 33 eyes of 33 patients with CS in a previously vitrectomized eye (the sequential surgery group). The control group was comprised of 130 eyes of 102 patients who underwent CS alone. All patients were followed up for at least 1 year after CS. The major outcome measures were the PCO rate and the interval between CS and PCO formation. There were no significant differences in age and the incidence of diabetes among the 3 groups. Results: The PCO rate checked at 1 year after CS was 12.5% (7/56) in the combined surgery group, 24.2% (8/33) in the sequential surgery group, and 4.6% (6/130) in the control group. The differences in the PCO rate between the subgroups as well as among the 3 groups were statistically significant (p < 0.05). There were no significant differences in the interval between CS and PCO formation among the 3 groups. Conclusion: This study demonstrates that the PCO rate may be lower in patients who have a combined procedure of PPV and CS than in those who have a sequential procedure.

1.
Blankenship GW: The lens influence on diabetic vitrectomy results. Report of a prospective randomized study. Arch Ophthalmol 1980;98:2196–2198.
2.
Blankenship GW, Machemer R: Long-term diabetic vitrectomy result. Report of 10 year follow-up. Ophthalmology 1985;92:503–506.
3.
Melberg NS, Thomas MA: Nuclear sclerotic cataract after vitrectomy in patients younger than 50 years of age. Ophthalmology 1995;102:1466–1471.
4.
Mamalis N, Teske MP, Kreisler KR, et al: Phacoemulsification combined with pars plana vitrectomy. Ophthalmic Surg 1991;22:194–198.
5.
Chung TY, Chung H, Lee JH: Combined surgery and sequential surgery comprising phacoemulsification, pars plana vitrectomy, and intraocular lens implantation. J Cataract Refract Surg 2002;28:2001–2005.
6.
Lahey JM, Francis RR, Kearney JJ: Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy. Ophthalmology 2003;110:1335–1339.
7.
Pinter SM, Sugar A: Phacoemulsification in eyes with past pars plana vitrectomy: case-control study. J Cataract Refract Surg 1999;25:556–561.
8.
Chang MA, Parides MK, Chang S, Braunstein RE: Outcome of phacoemulsification after pars plana vitrectomy. Ophthalmology 2002;109:948–954.
9.
Toda J, Kato S, Oshika T, Sugita G: Posterior capsule opacification after combined cataract surgery and vitrectomy. J Cataract Refract Surg 2007;33:104–107.
10.
Camparini M, Macalusa C, Reggiani L, Maraini G: Retroillumination versus reflected-light images in the photographic assessment of posterior capsule opacification. Invest Ophthalmol Vis Sci 2000;41:3074– 3079.
11.
Sellman TR, Lindstrom RL: Effect of a plano-convex posterior chamber lens on capsular opacification from Elschnig pearl formation. J Cataract Refract Surg 1988;14:68–72.
12.
Haimann MH, Abrams GW: Prevention of lens opacification during diabetic vitrectomy. Ophthalmology 1984;91:116–121.
13.
Lucke KH, Foerster MH, Laqua H: Long-term results of vitrectomy and silicone oil in 500 cases of complicated retinal detachments. Am J Ophthalmol 1987;104:624–633.
14.
Federman JL, Schubert HD: Complications associated with the use of silicone oil in 150 eyes after retinovitreous surgery. Ophthalmology 1988;95:870–876.
15.
Blodi BA, Paluska SA: Cataract after vitrectomy in young patients. Ophthalmology 1997;104:1092–1095.
16.
Sneed S, Parrish RK II, Mandelbaum S, O’Grady G: Technical problems of extracapsular cataract extractions after vitrectomy. Arch Ophthalmol 1986;104:1126–1127.
17.
Smiddy WE, Stark WJ, Michels RG, et al: Cataract extraction after vitrectomy. Ophthalmology 1987;94:483–487.
18.
Meldrum ML, Aaberg TM, Patel A, Davis J: Cataract extraction after silicone oil repair of retinal detachments due to necrotizing retinitis. Arch Ophthalmol 1996;114:885–892.
19.
Grusha YO, Masket S, Miller KM: Phacoemulsification and lens implantation after pars plana vitrectomy. Ophthalmology 1998;105:287–294.
20.
Koenig SB, Mieler WF, Han DP, Abrams GW: Combined phacoemulsification, pars plana vitrectomy and posterior chamber intraocular lens insertion. Arch Ophthalmol 1992;110:1101–1104.
21.
Scharwey K, Pavlovic S, Jacobi KW: Combined clear corneal phacoemulsification, vitreoretinal surgery, and intraocular lens implantation. J Cataract Refract Surg 1999;25:693–698.
22.
Senn P, Schipper I, Perren B: Combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in the capsular bag: a comparison to vitrectomy and subsequent cataract surgery as a two-step procedure. Ophthalmic Surg Lasers 1995;26:420–428.
23.
Kadonosono K, Matsumoto S, Uchio E, et al: Iris neovascularization after vitrectomy combined with phacoemulsification and intraocular lens implantation for proliferative diabetic retinopathy. Ophthalmic Surg Lasers 2001;32:19–24.
24.
Suzuki Y, Sakuraba T, Mizutani H, et al: Postoperative complications after simultaneous vitrectomy and cataract surgery. Ophthalmic Surg Lasers 2001;32:391–396.
25.
Lahey JM, Francis RR, Fong DS, et al: Combining phacoemulsification with vitrectomy for treatment of macular holes. Br J Ophthalmol 2002;86:876–878.
26.
Demetriades AM, Gottsch JD, Thomsen R, et al: Combined phacoemulsification, intraocular lens implantation, and vitrectomy for eyes with coexisting cataract and vitreoretinal pathology. Am J Ophthalmol 2003;135:291–296.
27.
Nishi O, Nishi K, Osakabe Y: Effect of intraocular lenses on preventing posterior capsule opacification: design versus material. J Cataract Refract Surg 2004;30:2170–2176.
28.
Vasavada AR, Chauhan H, Shah G: Incidence of posterior capsular plaque in cataract surgery. J Cataract Refract Surg 1997;23:798–802.
29.
Peng Q, Hennig A, Vasavada AR, Apple DJ: Posterior capsular plaque: a common feature of cataract surgery in the developing world. Am J Ophthalmol 1998;125:621–626.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.